Results 61 to 70 of about 87,373,768 (197)

Community-Centered Patient Journey Map in Opioid Use Disorder: A Tool to Address Compassion Fatigue among Community Pharmacists

Pharmacy, 2023
Community pharmacists have become increasingly exposed to opioid use disorders in recent decades. However, both pharmacist training and traditional practice environments have not been adequate to prepare the pharmacist for both the patient care needs and
Kenneth Charles Hohmeier, Alina Cernasev, Christina Leibold, Todd M. Moore, Erica Schlesinger, Gerald Cochran, Ileana Arce, Wesley Geminn, Marie Chisholm-Burns   +8 more
doaj   +1 more source

Rapid Access to Medications for Opioid Use Disorder [PDF]

Journal of General Internal Medicine, 2021
Robert A. Kleinman, Nathaniel P. Morris
openaire   +2 more sources

Medication-Assisted Treatment of Adolescents With Opioid Use Disorders [PDF]

Pediatrics, 2016
Opioid use disorder is a leading cause of morbidity and mortality among US youth. Effective treatments, both medications and substance use disorder counseling, are available but underused, and access to developmentally appropriate treatment is severely restricted for adolescents and young adults.
Sheryl A. Ryan, Pamela K. Gonzalez, Stephen W. Patrick, Joanna Quigley, Lorena Siqueira, Leslie R. Walker   +5 more
openaire   +2 more sources

Deviations from the standard of care in the treatment of pregnant people with opioid use disorder in jails; a mixed methods study

BMC Pregnancy and Childbirth
Background Medications for opioid use disorder (MOUD) with methadone or buprenorphine are the standard of care for opioid use disorder (OUD) during pregnancy and postpartum. MOUD is not routinely available in US jails.
Sonia Hamilton, Erin Sommers, Camille Kramer, Carolyn Sufrin   +3 more
doaj   +1 more source

Mental Health Professionals’ Perception of Medications for Opioid Use Disorder [PDF]

, 2023
Despite the widespread attention and resources allocated to the current opioid crisis, the public health problem persists. A major target in the efforts to combat the opioid crisis is increased accessibility and utilization of medications for opioid use ...
Mullen, Patrick M
core   +1 more source

Prevalence, patterns, and predictors of prescribing medications for opioid use disorder (MOUD) in the Inpatient setting

Drug and Alcohol Dependence Reports
Background: There are many barriers to prescribing medications for opioid use disorder (MOUD). This study evaluates the prevalence, patterns, and predictors of inpatient MOUD prescribing at discharge to patients with a diagnosis of opioid use/opioid use ...
Ashley Burke, Nina Vadiei, Lea Mollon
doaj   +1 more source

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Addiction Science & Clinical Practice, 2022
Background Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death.
Breanne E. Biondi, Brent Vander Wyk, Esther F. Schlossberg, Albert Shaw, Sandra A. Springer   +4 more
doaj   +1 more source

Barriers to accessing medications for opioid use disorder among rural individuals. [PDF]

Int J Drug Policy
Background: Individuals with opioid use disorder living in rural areas face barriers to accessing medications for treatment (MOUD), including finding prescribing clinicians and difficulties with transportation. This study sought to describe self-reported
Morenz AM, Nance RM, Mixson LS, Feinberg J, Smith G, Korthuis PT, Pho MT, Jenkins WD, Friedmann PD, Stopka TJ, Fanucchi LC, Miller WC, Go VF, Westergaard R, Seal DW, Zule WA, Crane HM, Delaney JA, Tsui JI.   +18 more
europepmc   +2 more sources

Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder

Addiction Science & Clinical Practice
Background Medications for opioid use disorder (MOUD) are among the best tools available to combat the opioid epidemic. Yet, use of MOUD among people with opioid use disorder (OUD) remains low.
Nicholas C. Cardamone, Rebecca E. Stewart, Kyle M. Kampman, Steven C. Marcus   +3 more
doaj   +1 more source

Longitudinal Access to Medications for Opioid Use Disorder

, 2023
This image of continental US maps shows spatial access to methadone in 1984 and 2017. Amid the ongoing opioid epidemic in the United States, access to methadone approved for the treatment of opioid use disorder (OUD) is increasingly critical to reducing ...
Morioka, Wataru
core